|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-04
|
$701,778
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
MOTILITY AND INVASION
|
5P01CA100324-15
|
$2,028,990
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Training of Surgeons for Studies of the Tumor Microenvironment
|
5T32CA200561-03
|
$277,522
|
|
MICHLER, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mechanisms of Formation and Progression of Preleukemic Stem Cells
|
1R01CA217092-01
|
$397,371
|
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methods in Clinical Cancer Research Workshop
|
5R25CA068647-20
|
$224,999
|
|
VON HOFF, DANIEL
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
2017 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA217139-01
|
$7,000
|
|
MITCHELL, RICHARD
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
Cancer-associated fibroblast in the regulation of bladder cancer stem cells
|
5R01CA175397-05
|
$324,738
|
|
CHAN, KEITH SYSON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
|
5R01CA072038-19
|
$320,963
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Germ Cell Gene TDRD1 As A Novel Prostate Cancer Biomarker
|
1R01CA211861-01A1
|
$362,569
|
|
HE, BIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes
|
5K07CA181480-04
|
$127,883
|
|
LIU, YANHONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-04
|
$2,300,000
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Evaluating utility and improving implementation of genomic sequencing for pediatr
|
U01HG006485-05
|
$900,000
|
|
Plon, Sharon
|
BAYLOR COLLEGE OF MEDICINE
|
|
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
|
5R01CA181808-04
|
$336,565
|
|
RICHARDS, JOANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Delineating racially distinct metabolic pathways in triple negative breast cancer
|
5U01CA179674-04
|
$334,143
|
|
SREEKUMAR, ARUN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc
|
5R01CA183878-04
|
$324,738
|
|
ZHANG, XIANG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
|
5R01CA184585-04
|
$802,610
|
|
NEUHAUSEN, SUSAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-03
|
$1,041,188
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
RASL-Seq Expression Profiling of FFPE Tissues
|
5R33CA183688-03
|
$332,225
|
|
YEAKLEY, JOANNE
|
BIOSPYDER TECHNOLOGIES, INC.
|
|
MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
|
5R01CA176203-04
|
$343,900
|
|
GODLEWSKI, JAKUB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
(PQ4) Elucidating Determinants of Susceptibility to Tumorigenesis in the Skin
|
5R21CA208298-02
|
$180,459
|
|
RAMSEY, MATTHEW
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the HSF1 Cancer Network
|
5R01CA194005-02
|
$406,031
|
|
SANTAGATA, SANDRO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-18
|
$2,424,605
|
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Systematic identification of oncogenic KRAS synthetic lethal interactions
|
5U01CA199253-03
|
$807,776
|
|
HAHN, WILLIAM
|
BROAD INSTITUTE, INC.
|
|
A Pap Test Intervention to Enhance Decision Making among Pacific Islander Women
|
5R01CA149324-02
|
$498,557
|
$498,557
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
|
Epigenetically Reversing Paclitaxel Resistance in Triple Negative Breast Cancers
|
1F32CA210426-01A1
|
$61,866
|
|
GAYLE, SYLVIA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
MR Fingerprinting and Computerized Decision Support for Prostate Cancer
|
1R01CA208236-01A1
|
$554,035
|
|
GULANI, VIKAS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Imaging Liver Cancer Proliferation
|
5R01CA204373-02
|
$395,646
|
|
LEE, ZHENGHONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeted MRI contrast agents for differential diagnosis of prostate cancer
|
1R01CA211762-01A1
|
$423,352
|
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
|
5R01CA196687-03
|
$209,873
|
|
MUZIC, RAYMOND
|
CASE WESTERN RESERVE UNIVERSITY
|
|
High resolution volumetric MRI for prostate cancer active surveillance
|
1R01CA217098-01
|
$373,652
|
|
KIM, HYUNG
|
CEDARS-SINAI MEDICAL CENTER
|
|
FrostBite-BC - A New Thermal Ablation Device for Treating Bladder Cancer
|
1R43CA210761-01A1
|
$308,550
|
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia
|
5K08CA184418-04
|
$169,657
|
|
TASIAN, SARAH
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Novel mechanisms and therapeutic strategies of refractory leukemia
|
1F31CA217140-01
|
$36,724
|
|
MELGAR, KATELYN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Academy of Behavioral Medicine Research Annual Conference
|
1R13CA216984-01
|
$7,580
|
|
MCCUBBIN, JAMES
|
CLEMSON UNIVERSITY
|
|
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
|
5R01CA184137-03
|
$362,569
|
|
ALMASAN, ALEXANDRU
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Epigenetic Regulation of Lipid Metabolism in Glioma Stem Cells
|
1F30CA217065-01
|
$44,044
|
|
GIMPLE, RYAN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
The Role of DDX41 in the Spliceosome and Myeloid Neoplasia
|
5F31CA192885-03
|
$38,328
|
|
HIZNAY, JAMES
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
The Unfolded Protein Response in Glioblastoma
|
1F30CA217066-01
|
$47,203
|
|
PRAGER, BRIANA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Elucidating the role of microRNAs in the initiation of multiple myeloma
|
5R00CA172292-05
|
$248,999
|
|
ZHAO, JIANJUN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-03
|
$154,908
|
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL Eukaryotic DNA Replication & Genome Maintenance Conference
|
1R13CA217040-01
|
$3,000
|
|
STEWART, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL Eukaryotic mRNA Processing Conference
|
1R13CA217123-01
|
$4,000
|
|
STEWART, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL Telomeres and Telemerase Conference
|
R13AG056095-01
|
$3,000
|
|
STEWART, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
Centers for Cancer Systems Therapeutics (CaST)
|
5U54CA209997-02
|
$1,991,657
|
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
|
5R01CA196932-03
|
$387,027
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Unlocking the Potential of PI3K Inhibition in CLL
|
1R01CA213442-01A1
|
$595,146
|
|
BROWN, JENNIFER
|
DANA-FARBER CANCER INST
|
|
MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL
|
5R01CA182736-05
|
$699,439
|
|
GRAY, NATHANAEL
|
DANA-FARBER CANCER INST
|
|
Dissecting the Mitochondrial Translocation Mechanism of Anti-Apoptotic BCL-w
|
5F31CA210592-02
|
$44,044
|
|
HARVEY, EDWARD
|
DANA-FARBER CANCER INST
|
|
Structure-Function Analysis of a Novel Inhibitory Mechanism for Pro-Apoptotic BAK
|
5F31CA210590-02
|
$44,044
|
|
HAUSEMAN, ZACHARY
|
DANA-FARBER CANCER INST
|
Total relevant funding to Cervical Cancer Education for this search: $6,565,854
|